Ignite Creation Date:
2025-12-24 @ 4:56 PM
Ignite Modification Date:
2026-01-07 @ 1:32 AM
Study NCT ID:
NCT02735850
Status:
WITHDRAWN
Last Update Posted:
2017-05-23
First Post:
2016-03-22
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination of SABR and L19-IL2 in Patients With Stage IV Lung Cancer (ImmunoSABR)
Sponsor:
Maastricht Radiation Oncology
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Oligometa's L19-IL2
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None